174 related articles for article (PubMed ID: 31150762)
1. Glioma stages prediction based on machine learning algorithm combined with protein-protein interaction networks.
Niu B; Liang C; Lu Y; Zhao M; Chen Q; Zhang Y; Zheng L; Chou KC
Genomics; 2020 Jan; 112(1):837-847. PubMed ID: 31150762
[TBL] [Abstract][Full Text] [Related]
2. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
[TBL] [Abstract][Full Text] [Related]
3. Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis.
Jiang Y; He J; Guo Y; Tao H; Pu F; Li Y
J Cell Biochem; 2020 Jun; 121(5-6):3099-3111. PubMed ID: 31886582
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
5. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
Xia P; Li Q; Wu G; Huang Y
J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841
[TBL] [Abstract][Full Text] [Related]
6. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
[TBL] [Abstract][Full Text] [Related]
7. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
He Y; Ma J; Ye X
Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
[TBL] [Abstract][Full Text] [Related]
8. Screening critical genes associated with malignant glioma using bioinformatics analysis.
Xu Y; Wang J; Xu Y; Xiao H; Li J; Wang Z
Mol Med Rep; 2017 Nov; 16(5):6580-6589. PubMed ID: 28901452
[TBL] [Abstract][Full Text] [Related]
9. Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.
De Looze C; Beausang A; Cryan J; Loftus T; Buckley PG; Farrell M; Looby S; Reilly R; Brett F; Kearney H
J Neurooncol; 2018 Sep; 139(2):491-499. PubMed ID: 29770897
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis identified RGS4 as a potential tumor promoter in glioma.
Wu L; Wang J; Zhao J; Yao R; Xu Q; Ma L; Liu J
Pathol Res Pract; 2022 Dec; 240():154225. PubMed ID: 36423402
[TBL] [Abstract][Full Text] [Related]
11. Identification of WHO II/III Gliomas by 16 Prognostic-related Gene Signatures using Machine Learning Methods.
Wu YM; Sa Y; Guo Y; Li QF; Zhang N
Curr Med Chem; 2022; 29(9):1622-1639. PubMed ID: 34455959
[TBL] [Abstract][Full Text] [Related]
12. Radiogenomics of lower-grade gliomas: machine learning-based MRI texture analysis for predicting 1p/19q codeletion status.
Kocak B; Durmaz ES; Ates E; Sel I; Turgut Gunes S; Kaya OK; Zeynalova A; Kilickesmez O
Eur Radiol; 2020 Feb; 30(2):877-886. PubMed ID: 31691122
[TBL] [Abstract][Full Text] [Related]
13. A quantitative model based on clinically relevant MRI features differentiates lower grade gliomas and glioblastoma.
Cao H; Erson-Omay EZ; Li X; Günel M; Moliterno J; Fulbright RK
Eur Radiol; 2020 Jun; 30(6):3073-3082. PubMed ID: 32025832
[TBL] [Abstract][Full Text] [Related]
14. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
Chen J; Hou C; Wang P; Yang Y; Zhou D
World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
[TBL] [Abstract][Full Text] [Related]
15. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile analysis of U251 glioma cells with shRNA-mediated SOX9 knockdown.
Ren D; Yang C; Liu N; Wang Z; Wang X; Johnson M; Wang W; Zhang P; Yang H; Liu H; Cheng Y; Wang L; Tu Y
J BUON; 2018; 23(4):1136-1148. PubMed ID: 30358223
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gene expression profiles associated with glioma progression.
Hu G; Wei B; Wang L; Wang L; Kong D; Jin Y; Sun Z
Mol Med Rep; 2015 Aug; 12(2):1884-90. PubMed ID: 25845910
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiles for insular low-grade gliomas with putamen involvement.
Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L
J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911
[TBL] [Abstract][Full Text] [Related]
20. Cysteine-rich 61-associated gene expression profile alterations in human glioma cells.
Wang R; Wei B; Wei J; Tian Y; Du C
Mol Med Rep; 2017 Oct; 16(4):5561-5567. PubMed ID: 28849002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
